Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSME-IMMUN in NIAID workers at risk of TBEV exposure
NCT01031537Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2009
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 2 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2009; status: terminated.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT01031537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01031537.